Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...

At the World Conference on Lung Cancer (WCLC ... I-DXd targets B7-H3, a protein overexpressed on the surface of a wide variety of cancer cells that binds to the CD28 family of receptors, which ...

A single-cell transcriptomic profile of oligodendrocyte precursor cells in the brain across the mouse lifespan reveals aging-associated changes that contribute to the decline of oligodendrogenesis ...